Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rebamipide for Prevention of Gout Attacks During Febuxostat Therapy
ChiCTR2300078984Phase 4Recruiting
- Sponsor
- Anqing City Hospital
- Start
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of rebamipide in gout (3 arms), sponsored by Anqing City Hospital. Primary endpoints: Blood uric acid and Number of gout attacks. Started Dec 2023; status: recruiting.
02
Drugs
rebamipide
03
Conditions
gout
Beyond the preview
Go deeper on ChiCTR2300078984.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300078984.